Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Tourmaline Bio Dividend Announcement
• Tourmaline Bio announced a annually dividend of $1.51 per ordinary share which will be made payable on . Ex dividend date: 2023-10-20
• Tourmaline Bio's trailing twelve-month (TTM) dividend yield is -%
Tourmaline Bio Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2023-10-20 | $1.51 | annually |
Tourmaline Bio Dividend per year
Tourmaline Bio Dividend Yield
Tourmaline Bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tourmaline Bio stock? Use our calculator to estimate your expected dividend yield:
Tourmaline Bio Financial Ratios
P/E ratio-14.94
PEG ratio-0.15
P/B ratio2.27
ROE-16.04%
Payout ratio0.00%
Current ratio40.33
Quick ratio40.33
Cash Ratio4.81
Tourmaline Bio Dividend FAQ
Does Tourmaline Bio stock pay dividends?
Tourmaline Bio does not currently pay dividends to its shareholders.
Has Tourmaline Bio ever paid a dividend?
No, Tourmaline Bio has no a history of paying dividends to its shareholders. Tourmaline Bio is not known for its dividend payments.
Why doesn't Tourmaline Bio pay dividends?
There are several potential reasons why Tourmaline Bio would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tourmaline Bio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tourmaline Bio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tourmaline Bio a dividend aristocrat?
Tourmaline Bio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tourmaline Bio a dividend king?
Tourmaline Bio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tourmaline Bio a dividend stock?
No, Tourmaline Bio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tourmaline Bio stocks?
To buy Tourmaline Bio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Tourmaline Bio stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Tourmaline Bio stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.